Cancer survivors may carry hidden aging markers that raise disease risk

NCT ID NCT07114614

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study will compare levels of fatty acid binding proteins and cellular aging markers in 120 cancer survivors versus people who never had cancer. Researchers want to see if these markers are higher in survivors and linked to conditions like diabetes and high blood pressure. Participants will provide blood samples, and no treatment is given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help identify biomarkers that predict chronic disease risk in cancer survivors, potentially guiding future preventive care.

What could go wrong

This is an observational study with no treatment being tested. It is early-stage research, and findings may not lead to direct clinical changes or apply to all survivors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Case Comprehensive Cancer Center, UH Rainbow Babies & Children's Hospital

    RECRUITING

    Cleveland, Ohio, 44106, United States

    Contact